Document is current
Any future updates will be listed below
-
Authors
Gao, Yibo
Cao, Dandan
Li, Mengfan
Zhao, Fuqiang
Wang, Pei
Mei, Shiwen
Song, Qianqian
Wang, Pei
Nie, Yanli
Zhao, Wei
Wang, Sizhen
Yan, Hai
Wang, Xishan
Jiao, Yuchen
Liu, Qian
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82122053, 82225033)
Chinese Academy of Medical Sciences (2021-I2M-1-067, 2021-I2M-1-067)
Special Project for Research and Development in Key areas of Guangdong Province (2021B0101420005)
Shenzhen Science and Technology Innovation Program (RCJC20221008092811025)
Sanming Project of Medicine in Shenzen Municipality (SZSM202211011)
National Key Research and Development Program of China (2019YFC1315705)
- License Information
-
More Information
Article History
Received: 11 December 2023
Accepted: 13 February 2024
First Online: 22 August 2024
Declarations
:
: This study was approved by the Ethics Committee of the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval Number: 20/355–2551). All the participants provided written informed consent.
: All the authors have read and approved the final manuscript for publication.
: S.W. is the founder and has owner interest in Genetron Holdings. H.Y. is the founder, has owner interest in Genetron Holdings, and receives royalties from Agios, Genetron and Personal Genome Diagnostics (PGDX). Y.J. is one of the cofounders, has owner interest in Genetron Holdings, and receives royalties from Genetron. Other authors declare no conflict of interest.
